Kroll’s client, a U.S. biotech company, had to defend against an “infodemic” of misinformation happening online—all while producing a vaccine for the COVID-19 outbreak. Agility and speed are core to the client’s work on immunizations for serious global infectious diseases, and a similar approach had to be taken when managing the company’s social media presence. The company handled sporadic consumer engagements about clinical trials using traditional social listening tools. However, in its preparations to produce a huge number of doses per month, the company quickly realized a formal risk intelligence solution was needed.
The race to develop lifesaving COVID-19 vaccines sparked a firestorm of digital chatter on social media. From misinformation to conspiracy theories, pharma companies faced an unprecedented blitz of harmful content from bad actor groups. Meanwhile, as consumers sought answers about these remarkable scientific achievements, vaccine manufacturers had to create safe, compliant online communities to address their questions and concerns.
Our client employed Kroll to tackle misinformation head-on. We immediately began monitoring and managing the anticipated digital chatter set to overwhelm its communications, social media and compliance teams. The client needed help to categorize and prioritize the level of risk and anticipate the severity of social media commentary as it skyrocketed. Kroll quickly scaled to meet the growing demands placed on the company’s owned social media pages, 24/7/365. This included Facebook, Instagram, Twitter and LinkedIn pages across multiple languages and geographies.
Within weeks of partnering with Kroll, the volume of digital chatter on the biotech company’s social media pages rose sharply. The nonstop news cycle about COVID-19 vaccines, coupled with a tidal wave of misinformation, showed no signs of slowing; but the company and Kroll were ready, employing its real-time risk intelligence solution to keep pace with the harmful content and identify security and manufacturing risks as vaccine production began. Embedded within the company’s pharmacovigilance team, Kroll provided best practices in addition to rapid response, recording, reporting and the escalation of harmful content.
In just six months, Kroll reviewed and scanned 250,000 comments for potential adverse events. More than 10,000 items were categorized as misinformation. The company gained a trusted reporting system to grow alongside the distribution of its COVID-19 vaccine.
Kroll’s fast, actionable risk intelligence gives the biotech company and its teams 24/7/365 protection from reputational damage, as well as best-in-class adverse event detection with zero misses. This peace of mind also means the company can successfully (and securely) scale new vaccines and drug launches into new regions with the proper social media moderation and auditing solutions in place.
Need help staying ahead of a complex challenge?
Kroll’s fast, actionable risk intelligence gives the biotech company and its teams 24/7/365 protection from reputational damage, as well as best-in-class adverse event detection with zero misses. This peace of mind also means the company can successfully (and securely) scale new vaccines and drug launches into new regions with the proper social media moderation and auditing solutions in place.
Need help staying ahead of a complex challenge?
Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.
Incident response, digital forensics, breach notification, security strategy, managed security services, discovery solutions, security transformation.
End-to-end governance, advisory and monitorship solutions to detect, mitigate and remediate security, legal, compliance and regulatory risk.
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
World-wide expert services and tech-enabled advisory through all stages of diligence, forensic investigation, litigation, disputes and testimony.
Enriching our professional services, our integrated software platform helps clients discover, quantify and manage risk in the corporate and private capital market ecosystem.
Expert provider of complex administrative solutions for capital events globally. Our services include claims and noticing administration, debt restructuring and liability management services, agency and trustee services and more.
Advisory and technology solutions, including policies and procedures, screening and due diligence, disclosures and reporting and investigations, value creation, and monitoring.
